D-0647-2024 Class II Ongoing
FDA drug recall D-0647-2024 was initiated by Preferred Pharmaceuticals, Inc. on August 8, 2024 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications - at 18-month Stability testing The recall status is ongoing. Affected quantity: 266 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- September 4, 2024
- Initiation Date
- August 8, 2024
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 266 bottles
Product Description
Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories, Louisiana, Shreveport, NDC 68788-9110-03.
Reason for Recall
Failed Impurities/Degradation Specifications - at 18-month Stability testing
Distribution Pattern
CA and NV
Code Information
Lot: B0223H, Exp: 5/31/2026; C3023H, Exp: 9/30/2026.